Phase II trial of docetaxel (D) plus gefitinib (G) in elderly (≥70 years) patients with advanced stage non-small cell lung cancer (ANSCLC)
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: C. Williams, G. Bepler, M. Begum, A. Chiappori, R. Arora, E. Haura, S. Antonia, M. Extermann, G. Simon
Institution: Moffitt Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2972747354